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SC INBRE Grant
ABSTRACT
Oct4 is a protein that is involved in the retention of pluripotency in adipose derived stem cells
(ADSCs). Despite this knowledge, Oct4’s exact role in the complex system used in maintaining
pluripotency is not known. One approach to explore Oct4’s role would be through the use of
cellular assays to control the expression of Oct4. This can possibly be accomplished by introducing a
biological switch and the gene of interest into ADSCs. In this project, the GeneSwitch™ System is
used to ultimately induce Oct4 expression. Before the GeneSwitch™ System can be used, the Oct4
gene is extracted from murine embryonic stem cell (ES) RNA. This ES RNA is then used as a
template to create complimentary DNA (cDNA) that can then be used to create an insert with the
Oct4 gene. In addition to the cDNA, recognition sites for endonucleases must be added on to fully
create the Oct4 insert. This insert could then be placed into one of the GeneSwitch™ System
plasmids that have the same recognition sites and placed into ADSCs along with the plasmid that
will act as a biological switch. With this system put into ADSCs, it is expected that Oct4 levels will
be successfully controlled. Once controlled, Oct4 expression can be tested and investigations can be
completed to determine how Oct4 expression levels influence pluripotency of ADSCs. This may
have significant impact on the creation of regenerative medicine.
cells that have not differentiated (i.e. specialized
into a specific type of cell), have many
possibilities in terms of what kind of cell they
can become; this ability or potential to become
any type of cell is referred to as pluripotency.
This characteristic makes them an important
resource in the field of regenerative medicine
and holds tremendous potential for the future
of all medicine (Pan et al. 2002). There are quite
a few sources from which stem cells can be
attained, but the most commonly discussed
origins of stem cells are bone marrow or
embryos.
Despite the potential and major
progress in the study of stem cells, there are still
some ethical and procedural issues that come
with stem cell retrieval. For example, the use of
embryonic stem cells presents a serious dilemma
for many U.S. citizens. Others raise concern
about the procedure to gather bone marrow
stem cells (BMSCs), a process that is relatively
expensive, intrusive, and has a comparatively

INTRODUCTION
Cells are the most basic living
component that make up an organism. They
divide, communicate, metabolize, transport, and
complete many other tasks that the human body
requires in order to remain at homeostasis.
Remarkably, cells grouped together as tissues,
organs and organ systems can accomplish much
more complex regulatory processes than
individual cells. Since cells have such an
important role in the body, losing large amounts
of cells would make normal body functions
more difficult. The body is often able to replace
naturally lost cells, but may not be able to
replace large amounts of cells lost due to injury
or disease—at least not quickly. Regenerative
medicine has made major scientific progress in
procedures and tissue repair that can help the
body to replace cells on a larger scale. For
example, people who have been severely burned
can replace the lost tissue through the use of
regenerative medicine. Stem cells, immature
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low yield (Zhu et al. 2008). Adipose derived
stem cells (ADSCs) have become an attractive
alternative source; these cells are cheaper, easier
to obtain, and can be harvested in a much less
invasive manner. This can be attributed to the
abundance of fat available for medicinal use
from either the patient or willing donors (Zhu et
al. 2008). Not only is the use of ADSCs cheaper
and more efficient, it is also still capable of
having specified differentiation induced. This
can be seen through an experiment conducted
by Zhu et. al (2008), where ADSCs were
successfully induced to differentiate into fat
cells, bone cells, cartilage cells, and heart muscle
cells.
While stem cells are able to
differentiate, inducing their differentiation into
specific cells can be more difficult. Typically,
epigenetics—the study of how signals from an
environmental or external source affect genes—
plays a large role in the differentiation of stem
cells. Cells can respond to signals in different
ways based on many factors including: what
kind of signal is being sent, how strong the
signal is, and where the signal originates
(Weidgang et al. 2016). Certain signals are able
to trigger the stem cells to specifically
differentiate into a certain type of cell. Using
this same notion, it is possible for scientists to
create induced pluripotent stem cells (iPSCs)
that allow stem cell differentiation to be
controlled through many methods including the
use of a signal that can be operated using a
biological “switch” (Stadtfeld and Hochedlinger
2010). This “switch,” depending on what genes
it controls and what kinds of signals that gene is
in control of, would be used to control whether
the signal is “on” or “off” and the intensity of
the signal. In order to make use of a “switch” to
control stem cell differentiation, the gene of
interest would have to be a gene that plays a
role in the differentiation of stem cells. One
such gene could be Oct4, a transcription factor
that plays an important role in retaining the
pluripotency of stem cells (Kim et al. 2009).
Oct4 is usually used alongside many other
transcription factors such as Sox2, Nanog, Klf4,
and c-Myc in order to regulate the differentiation
and retention of pluripotency of a stem cell
(Takahashi and Yamanaka 2006). Typically,

many transcription factors are needed to control
pluripotency of stem cells as noted by the
research of Boyer et al. (2005) with embryonic
stem cells that are involved in the early stages of
embryo development. Out of the transcription
factors listed, Oct4 is the only one that is
absolutely essential for self-renewal and
pluripotency of a stem cell (Jerabek et al. 2014);
this means that there is a chance that controlling
the pluripotency of stem cells could possibly be
done by Oct4 only.
The work described here focused on
controlling Oct4 expression through the use of
Invitrogen’s GeneSwitch™ System. An insert
with Oct4 and two recognition sites had to be
made and introduced to the pGene vector of
the GeneSwitch System—which should have
the same recognition sites—through the use of
cloning. From there, further investigation can
be done to study whether the expression of
Oct4 alone can regulate the pluripotency of
murine ADSCs. Once more studies have been
completed using murine ADSCs, it will be
possible to expect many of the same findings
within human ADSCs due to the fact that the
Pou5f1 gene sequence that controls expression
of Oct4 for humans is 87% identical to that of
murine Pou5f1 (Jerabek et al. 2014).

METHODS
Embryonic stem cell ribonucleic acid
(ES RNA) was used as a template to create
complementary deoxyribonucleic acid (cDNA)
through the process of reverse transcription.
Reverse transcription is the formation of cDNA
using RNA as a template rather than the
formation of RNA from DNA that is seen with
normal transcription. An iScript™ Reverse
Transcription Supermix for quantitative reverse
transcription polymerase chain reaction (RTqPCR) from Bio-Rad and thermocycler were
used to create the cDNA. The reaction protocol
used to create the cDNA was 5 minutes of
priming at 25°C, 30 minutes of reverse
transcription at 42°C, and 5 minutes of reverse
transcriptase inactivation at 85°C. The cDNA
acted as a template for the polymerase chain
reaction (PCR) process used to amplify the
Oct4 gene for molecular cloning. The cDNA,
which already contained the Oct4 gene, was
40

reacted with oligonucleotide primers from
Eurofins Genomics containing recognition sites
for KpnI and NotI in order to make the Oct4
insert.
The
5’
primer
(5CTTGGTACCATGGCTGGACACCTGGCT
TCAGACTTCGCC) contained the recognition
site for KpnI and the 3’ primer (5-CGAG
CGGCCGCCCCCGTTTGAATGCATGGGA
GAGCCCAGAGCAGTG) contained the
recognition site for NotI. A 3’ primer with a
stop codon and the recognition site for NotI (5CGAGCGGCCGCCCCCTCAGTTTGAATG
CATGGGAGAGCCCAGAGCAGTG)
was
also used during PCR. The reaction protocol
used for PCR was 2 minutes of denaturing at
94°C, 30 seconds of denaturing at 94°C, 30
seconds of annealing at 50°C, 3 minutes of
elongation at 72°C, 1 minute of elongation at
72°C, and storage of PCR reaction at 4°C until
the PCR reaction is retrieved. The PCR reaction
went through 41 cycles of 30 seconddenaturing, 30 second-annealing, and 3 minuteelongation before moving on to the step of 1
minute-elongation. Gel electrophoresis was
completed and the gel was viewed through a
Gel Doc™ XR+ System to ensure that the
insert was the size it was expected to be. The
insert was removed from the gel and gel DNA
extraction was completed to purify the insert.
The insert and pGene vectors—from
Invitrogen’s GeneSwitch™ System—were then
digested in KpnI and NotI endonucleases at
37°C in a thermocycler to create the correct cuts
on both the insert and vector. The DNA of the
insert and vector was purified using gel
electrophoresis. Each sample was loaded on to a
1% agarose gel and separated for 30 minutes at
115V. The agarose gel containing the samples
was viewed under a Gel Doc™ XR+ System
from Bio-Rad using ethidium bromide to
invoke DNA fluorescence. The DNA was
carefully extracted from the gel and further
purified using the Gel DNA Extraction
protocol.

on a PCR reaction that incorporated cDNA and
Oct4 primers that could be used to identify
Oct4 using only a small segment of the Oct4
gene. It was expected that a band around 0.1kB
would appear in the agarose gel and a band was
present in the expected location as seen in
Figure 1.

Figure 1. Gel Electrophoresis results for the PCR
reaction including cDNA as the template and primers
to identify a short sequence of Oct4. The lowest lane
with bands contains the base pair ladder. The middle
lane with bands contained the PCR product for the
reaction using Oct4 primers and 0.5µL of cDNA. The
top lane with bands contained the PCR product for the
reaction using Oct4 primers and 2µL of cDNA. The
expected band size for this PCR reaction was 100 base
pairs or 0.1kB.

Once the cDNA was made, a PCR was
completed using a 5’ primer and 3’ primer to
add on recognition sites to the cDNA, but the
PCR product did not appear in the region it was
expected to be when it was viewed after running
a gel electrophoresis. It was expected to appear
around the 1kB region, but the band was found
well below the 0.5kB region as seen in Figure 2.
PCR reactions using various concentrations of
MgCl2 and DMSO were completed, but neither
reaction resulted in bands within the 1kB
region, as seen in Figure 3 and Figure 4; all
reactions resulted in bands well below the 0.5kB
region. A PCR reaction incorporating one of the
Oct4 primers used to confirm the successful
creation of cDNA and the 5’ primer was
completed along with a PCR reaction with the
other Oct4 primer and the 3’ primer. The
resulting gel, shown in Figure 5, indicates that
the reaction with the 3’ primer worked, but the
reaction with the 5’ primer did not.

RESULTS & DISCUSSION
ES RNA went through reverse
transcription to create cDNA with the desired
Oct4 gene. The presence of Oct4 in the cDNA
was confirmed by running a gel electrophoresis
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There are two possible reasons why the
PCR of the 5’ primer failed. One reason is that
the 5’ primer was not made correctly. Since the
primer was designed while looking specifically at
the expected cDNA sequence, there is very little
reason to believe that primer design is the cause
for this PCR to fail. The other possible reason is
that the reverse transcription of ES RNA to
make the cDNA did not completely work.
When reverse transcription happens, the primer
used during the process will find the template’s
poly-A tail in order to anneal to the 3’ end of
the mRNA. Once annealed, the primer will be
used to copy the mRNA to cDNA, but it may
not copy the entire template. This means that
some of the 5’ end of the cDNA is ultimately
missing. Without this 5’ end, the designed 5’
primer will not have an overlapping template
sequence to bind to and will not be able to
amplify the cDNA.
A PCR to figure out where the 5’ end of
the cDNA started was completed. Primers that
started at various intervals of the 5’ end of the
cDNA were made before being used in separate
PCR reactions. Each reaction also used the 3’
primer. A gel electrophoresis was completed
after the PCR and bands were seen just below
the desired region of 1kB, as seen in Figure 6.
The bands were also sequentially increasing—
which is what was expected—because of the
fact that each primer was closer to the 5’ end of
the cDNA than the last. With this PCR, it was
now known that the cDNA was completed at
least to the 50th nucleotide of the expected
cDNA sequence. It was decided that another
PCR would be completed to manually build on
the first 49 nucleotides. This PCR was
completed using two primers that would build
onto one another to form the remaining
nucleotides needed for the cDNA. A gel
electrophoresis was completed to see if the
appropriate bands could be found after each
build was added on to the cDNA and 3’ primer.
Bands around the 1kB marker were expected
and found after viewing the agarose gel as seen
in Figure 7.

Figure 2. Gel Electrophoresis results for the PCR
reaction including cDNA as the template, 5' primer
with a recognition site for KpnI, and 3’ primer with
recognition site for NotI. The lowest lane with bands
contains the base pair ladder. The second lowest lane
contains the control PCR reaction using WT NUR, T7
promoter primer, and T7 terminator primer. The
middle lane contains the PCR product for the reaction
with cDNA as the template, a 5’ primer with a KpnI
recognition site, and a 3’ primer with a NotI
recognition site. The second highest lane with bands
contains the PCR product for the reaction with cDNA
as the template, a 5’ primer with a KpnI recognition
site, and a 3’ primer with a NotI recognition site and a
stop codon. The highest lane with bands contains the
PCR product for the reaction with cDNA as the
template, a 5’ primer with a NdeI recognition site, and
a 3’ primer with a BamHI recognition site. The
expected band size for the PCR reactions (excluding
the control) were 1000 base pairs or 1kB.

Figure 3. Gel electrophoresis results for PCR reactions
with varying MgCl2 concentrations. Each PCR reaction
made use of cDNA as the template, a 5’ primer with a
KpnI recognition site, a 3’ primer with a NdeI
recognition site, and a specific concentration of MgCl 2.
The MgCl2 concentrations ranged from 0mM to 4mM
and increased in increments of 0.5mM.
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Figure 4. Gel electrophoresis results for PCR reactions
with varying DMSO percentages. Each PCR reaction
made use of cDNA as the template, a 5’ primer with a
KpnI recognition site, a 3’ primer with a NdeI
recognition site, and a specific concentration of
DMSO. The DMSO percentages ranged from zero
percent (0µL) to 3 percent (1.5µL).

Figure 6. Gel electrophoresis results for PCR reactions
with cDNA as the template, a 3' primer with a NotI
recognition site, and of the primers starting at various
intervals on the 5' end of the cDNA.

Figure 7. Gel electrophoresis results for PCR reactions
with cDNA as the template, a 3' primer with a NotI
recognition site, and either one or both of the Build
primers.

After the cDNA received the needed
recognition site from the 5’ primer, the newly
made Oct4 insert just needed to be cloned into
the pGene plasmid before the pGene and
pSwitch plasmids could then be transfected into
the murine ADSCs and Oct4 expression levels
could be investigated.

Figure 5. Gel electrophoresis results for PCR reactions
using cDNA as the template, one of the Oct4
identifying primers, and either the 5' primer or 3'
primer. The lowest lane with bands contained the base
pair ladder. The second lowest lane with bands
contained the PCR product for cDNA and the Oct4
identifying primers. The third lowest lane with bands
contained the PCR product for the cDNA, 5’ primer
with a KpnI recognition site, and one of the Oct4
identifying primers. The third highest lane with bands
contained the PCR product for cDNA, 3’ primer with a
NotI recognition site, and one of the Oct4 identifying
primers. The second highest lane with bands contained
the PCR product for cDNA, 5’ primer with NdeI, and
one of the Oct4 identifying primers. The highest lane
with bands contained the PCR product for cDNA, 3’
primer with BamHI, and one of the Oct4 identifying
primers.
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